Skip to main content
. 2013 Apr 17;2013:295791. doi: 10.1155/2013/295791

Table 2.

Genotype and allele frequencies of meningioma cases, glioma cases, and controls.

SNP Controls n (%)
(n = 122)
Meningioma n (%)
(n = 44)
χ 2 P value Glioma n (%)
(n = 56)
χ 2 P value
*Fok-I genotype
 FF 56 (45.9%) 19 (43.2%) 28 (50.0%)
 Ff 63 (51.6%) 18 (40.9%) 10.527 0.005 23 (41.1%) 4.598
0.1
 ff 3 (2.5%) 7 (15.9%) 5 (8.9%)
*Fok-1 alleles
 F 175 (71.7%) 56 (63.6%) 79 (70.5%)
 f 69 (28.3%) 32 (36.4%) 1.997 0.157 33 (29.5%) 0.052 0.818
#Taq-I genotype
 TT 65 (53.3%) 23 (52.3%) 32 (57.1%)
 Tt 44 (36.0%) 18 (40.9%) 0.703 0.704 18 (32.2%) 0.275
0.872
 tt 13 (10.7%) 3 (6.8%) 6 (10.7%)
#Taq-I alleles
 T 174 (71.3%) 64 (72.7%) 82 (73.2%)
 t 70 (28.7%) 24 (27.3%) 0.064 0.800 30 (26.8%) 0.137 0.710

Chi-square test was used to compare alleles and clinic pathological characteristics in the study group. n: number of individuals.

*For Fok 1 polymorphism (rs2228570): F is referred to as T allele, and f is referred to as C allele.

#For Taq 1 polymorphism (rs731236): T is referred to as T allele, and t is referred to as C allele.

Due to the same base changes T-C or C-T for both polymorphisms, it should be shown as the initial letter of the polymorphism.